Literature DB >> 12758209

The role of the community in the control of tuberculosis.

Dermot Maher1.   

Abstract

SETTING: High tuberculosis (TB) prevalence countries, where National TB programmes (NTPs) need to ensure widespread access to effective treatment.
OBJECTIVE: To review possible ways in which communities can contribute to TB control and to describe the project "Community TB Care in Africa".
DESIGN: A review of the literature on community contribution to TB control and a progress report on the project "Community TB Care in Africa".
RESULTS: Eight district-based projects in six countries (Botswana, Kenya, Malawi, South Africa, Uganda, Zambia) participated in the overall "Community TB Care in Africa" project. District TB programmes offering patients the choice of community or health facility treatment supervision generally performed effectively, with satisfactory rates of treatment success. Average health system and patient and family costs were lower in comparison with controls.
CONCLUSION: Investigators formulated policy recommendations. NTPs should: (1) extend TB care to the community to improve access; (2) identify suitable community TB treatment supporters in consultation with the community; (3) ensure that effective systems extend into the community for recording and reporting, and for supply of anti-TB drugs; (4) monitor community contribution to TB care using standard indicators; (5) develop costed plans for expansion of the community approach. Ministries of Health should: (1) ensure adequate financing; (2) coordinate the efforts of NTPs, donors and NGOs to ensure sustainability; (3) consider opportunities for collaboration between NTPs and HIV/AIDS programmes.

Entities:  

Mesh:

Year:  2003        PMID: 12758209     DOI: 10.1016/s1472-9792(02)00066-5

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  7 in total

1.  Trained community volunteers improve tuberculosis knowledge and attitudes among adults in a periurban community in southwest Nigeria.

Authors:  Mobolanle Balogun; Adekemi Sekoni; Seema Thakore Meloni; Oluwakemi Odukoya; Adebayo Onajole; Olukemi Longe-Peters; Folasade Ogunsola; Phyllis J Kanki
Journal:  Am J Trop Med Hyg       Date:  2014-12-15       Impact factor: 2.345

2.  Electronic monitoring of treatment adherence and validation of alternative adherence measures in tuberculosis patients: a pilot study.

Authors:  Jossy van den Boogaard; Ramsey A Lyimo; Martin J Boeree; Gibson S Kibiki; Rob E Aarnoutse
Journal:  Bull World Health Organ       Date:  2011-05-20       Impact factor: 9.408

3.  Access to tuberculosis diagnosis in Itaboraí City, Rio de Janeiro, Brazil: the patient's point of view.

Authors:  M C S Motta; T C S Villa; J Golub; A L Kritski; A Ruffino-Netto; D F Silva; R G Harter; L M Scatena
Journal:  Int J Tuberc Lung Dis       Date:  2009-09       Impact factor: 2.373

4.  3Ts of low cure rate: taxonomy, themes and theory of low cure rate in Pakistan's TB control programme and gathering a 360-degree perspective through qualitative, in-depth interviewing approach.

Authors:  Syed Mustafa Ali; Sumaira Hussain; Muhammad Ishaq; Shoukat Ali; Farah Naureen; Arif Noor; Aamna Rashid; Naveed Anjum
Journal:  BMJ Open       Date:  2019-07-09       Impact factor: 2.692

5.  Long distance travelling and financial burdens discourage tuberculosis DOTs treatment initiation and compliance in Ethiopia: a qualitative study.

Authors:  Takele Tadesse; Meaza Demissie; Yemane Berhane; Yigzaw Kebede; Markos Abebe
Journal:  BMC Public Health       Date:  2013-05-01       Impact factor: 3.295

6.  Barriers and enablers in the management of tuberculosis treatment in Addis Ababa, Ethiopia: a qualitative study.

Authors:  Mette Sagbakken; Jan C Frich; Gunnar Bjune
Journal:  BMC Public Health       Date:  2008-01-11       Impact factor: 3.295

7.  Home-Based and Facility-Based Directly Observed Therapy of Tuberculosis Treatment under Programmatic Conditions in Urban Tanzania.

Authors:  Francis Mhimbira; Jerry Hella; Thomas Maroa; Shadrack Kisandu; Magreth Chiryamkubi; Khadija Said; Grace Mhalu; Abdallah Mkopi; Beatrice Mutayoba; Klaus Reither; Sébastien Gagneux; Lukas Fenner
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.